00959nas a2200337   4500000000100000008004100001260001300042653004400055653002000099653001600119653003700135653002100172653001100193653001100204653002500215653000900240653001400249653004200263653001500305653003000320653001300350653002200363100001600385700001200401245009400413856005100507300001000558490000700568050003200575022001400607       2003                            d  c2003 Dec10aAnti-Inflammatory Agents, Non-Steroidal10aChronic Disease10aClofazimine10aDose-Response Relationship, Drug10aErythema Nodosum10aFemale10aHumans10aLeprosy, lepromatous10aMale10aPrognosis10aRandomized Controlled Trials as Topic10aRecurrence10aSeverity of Illness Index10aSteroids10aTreatment Outcome1 aSchreuder P1 aNaafs B00aChronic recurrent ENL, steroid dependent: long-term treatment with high dose clofazimine.  uhttps://leprosyreview.org/article/74/4/38-6389  a386-90 v74  aInfolep Library - available  a0305-7518